DJ, S., SA, B., V, B., W, H., G, A., J, Z., & V, R. (2025). Nedosiran in pediatric patients with PH1 and relatively preserved kidney function, a phase 2 study (PHYOX8). Pediatric nephrology (Berlin, Germany), 40(6), 1939. https://doi.org/10.1007/s00467-025-06675-8
Chicago Style (17th ed.) CitationDJ, Sas, Bakkaloglu SA, Belostotsky V, Hayes W, Ariceta G, Zhou J, and Rawson V. "Nedosiran in Pediatric Patients with PH1 and Relatively Preserved Kidney Function, a Phase 2 Study (PHYOX8)." Pediatric Nephrology (Berlin, Germany) 40, no. 6 (2025): 1939. https://doi.org/10.1007/s00467-025-06675-8.
MLA (9th ed.) CitationDJ, Sas, et al. "Nedosiran in Pediatric Patients with PH1 and Relatively Preserved Kidney Function, a Phase 2 Study (PHYOX8)." Pediatric Nephrology (Berlin, Germany), vol. 40, no. 6, 2025, p. 1939, https://doi.org/10.1007/s00467-025-06675-8.